BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Zhang P, Tian X, Chen G, Li Y, Zhang Y, Xu Z, Wei Z, Zhang W, Ma L, Shi B, Liao L, Wang J. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device. World J Urol 2019;37:2481-92. [PMID: 30809700 DOI: 10.1007/s00345-019-02698-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Meng L, Diao T, Wang M, Liu X, Zhang W, Tian Z, Wang J, Zhang Y. Variable frequency stimulation of sacral neuromodulation in black-zone overactive bladder patients: a case report. Transl Androl Urol 2020;9:2842-7. [PMID: 33457256 DOI: 10.21037/tau-20-889] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Liao L, Zhou Z, Chen G, Xu Z, Huang B, Chong T, Chen Q, Wei Z, Shen B, Chen Z, Ling Q, Weng Z, Jiang H, Shi B, Li Y, Wang Y. Sacral Neuromodulation Using a Novel Device with a Six-contact-point Electrode for the Treatment of Patients with Refractory Overactive Bladder: A Multicenter, Randomized, Single-blind, Parallel-control Clinical Trial. Eur Urol Focus 2022:S2405-4569(22)00083-9. [PMID: 35525837 DOI: 10.1016/j.euf.2022.04.006] [Reference Citation Analysis]
3 Dudding TC, Lehur PA, Sørensen M, Engelberg S, Bertapelle MP, Chartier-Kastler E, Everaert K, Van Kerrebroeck P, Knowles CH, Lundby L, Matzel KE, Muñoz-Duyos A, Rydningen MB, de Wachter S. Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice. Neuromodulation 2021. [PMID: 34264542 DOI: 10.1111/ner.13494] [Reference Citation Analysis]
4 Owolabi EO, Mac Quene T, Louw J, Davies JI, Chu KM. Telemedicine in Surgical Care in Low- and Middle-Income Countries: A Scoping Review. World J Surg. [DOI: 10.1007/s00268-022-06549-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Meng L, Tian Z, Zhang W, Zhang Y, Wang J, Liao L, Ling Q, Zhang P, Wei Z, Zhong T, Xu Z, Wen W, Li J, Luo D. Influence of patient sex on the effectiveness of sacral neuromodulation: A cohort study from China. Int J Surg 2020;84:13-7. [PMID: 33080412 DOI: 10.1016/j.ijsu.2020.10.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Meng L, Tian Z, Diao T, Wang M, Liu X, Zhang W, Wang J, Zhang Y. Variable- versus constant-frequency sacral neuromodulation in black-zone overactive bladder patients: a study protocol for a multicenter, prospective, randomized, blind, self-controlled trial. Transl Androl Urol 2021;10:504-11. [PMID: 33532338 DOI: 10.21037/tau-20-1257] [Reference Citation Analysis]
7 Girtner F, Burger M, Mayr R. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments]. Urologe A 2019;58:634-9. [PMID: 31139864 DOI: 10.1007/s00120-019-0949-7] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Dequirez PL, Biardeau X. Randomized clinical trials assessing third-line therapies to treat non-neurogenic overactive bladder syndrome: a review about methodology. Int Urogynecol J 2021. [PMID: 33770228 DOI: 10.1007/s00192-021-04688-z] [Reference Citation Analysis]
9 Zhang Y, Meng L, Zhang P, Tian X, Chen G, Li Y, Zhang Y, Xu Z, Wei Z, Zhang W, Ma L, Shi B, Liao L, Wang J. Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder. Transl Androl Urol 2021;10:1966-75. [PMID: 34159077 DOI: 10.21037/tau-21-43] [Reference Citation Analysis]